Related Experiment Videos
E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
A C Phillips1, M K Ernst, S Bates
1ABL Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland 21702, USA.
Abstract:
The E2F family of transcription factors plays an essential role in promoting cell cycle progression, and one member of the family, E2F-1, is also capable of inducing apoptosis. We show here that E2F-1 can induce apoptosis by a death receptor-dependent mechanism, by downregulating TRAF2 protein levels and inhibiting activation of antiapoptotic signals including NF-kappa B. In this way, E2F-1 expression can lead to the sensitization of cells to apoptosis by a number of agents independently of p53. Deregulation of E2F-1 activity occurs in the majority of human tumors, and the ability of E2F-1 to inhibit antiapoptotic signaling may contribute to the enhanced sensitivity of transformed cells to chemotherapeutic agents.
Insights
The transcription factor E2F-1 induces cell death by downregulating TRAF2 and inhibiting antiapoptotic signals. This mechanism sensitizes cells to apoptosis independently of p53, impacting cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The E2F family of transcription factors regulates cell cycle progression.
- E2F-1 is a key member known to induce apoptosis.
- Dysregulation of E2F-1 is common in human tumors.
Purpose of the Study:
- To elucidate the mechanism by which E2F-1 induces apoptosis.
- To investigate the role of E2F-1 in sensitizing cells to apoptosis independently of p53.
- To explore the implications of E2F-1's function in cancer chemotherapeutics.
Main Methods:
- Investigated E2F-1's apoptotic pathway.
- Assessed TRAF2 protein levels following E2F-1 expression.
- Analyzed the inhibition of antiapoptotic signaling pathways, including NF-kappa B.
- Examined p53-independent sensitization to apoptosis.
Main Results:
- E2F-1 induces apoptosis via a death receptor-dependent pathway.
- E2F-1 downregulates TRAF2 protein levels.
- E2F-1 inhibits the activation of antiapoptotic signals like NF-kappa B.
- E2F-1 sensitizes cells to apoptosis independently of p53.
Conclusions:
- E2F-1 promotes apoptosis by downregulating TRAF2 and inhibiting NF-kappa B signaling.
- E2F-1-mediated apoptosis is p53-independent.
- E2F-1's ability to inhibit antiapoptotic signals may enhance the sensitivity of cancer cells to chemotherapy.